The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...
Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...
2h
MarketBeat on MSNPharma Frenzy: Volatility Ignites Biotech SectorThe biotechnology sector has experienced a jolt of volatility over the past few days, spearheaded by the dramatic price ...
WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...
4hOpinion
Zacks Investment Research on MSN5 Large Drug Stocks to Watch as Industry RecoversThe drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...
The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...
The global pharmaceuticals market is estimated to reach $1.21 trillion in 2025, according to Statista data. Overall, Statista predicted the worldwide pharma industry market revenue will increase 4 ...
5d
Zacks.com on MSNARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat EstimatesARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of 1,400% and 273.26%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...
Discover the projected growth and lucrative markets in the global pharmaceutical industry, with a focus on oncology and other therapeutic areas, per Statista.
Sun Pharmaceutical Industries Limited has announced the completion of its 100% acquisition of Antibe Therapeutics Inc., a ...
Analysts have recently evaluated Ultragenyx Pharmaceutical and provided 12-month price targets. The average target is $104.8, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results